SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NEOG - Neogen, Anybody have any info on this one??
NEOG 6.865-2.8%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ken Sims who wrote (90)4/16/1997 10:34:00 PM
From: Ken Sims   of 139
 
Buy reiterated by Roney & Co

=====

RESEARCH ALERT - Neogen (NASDAQ:NEOG) buy reiterated

Reuters, Wednesday, April 16, 1997 at 20:01

-- Roney & Co analyst Lynn Malkes said Wednesday she
reiterated her buy recommendation on Neogen Corp.
-- Neogen has a product line of more than 140 diagnostic
test kits for food safety, plant diseases, animal health,
pharmacologic research and human clinical testing.
-- Malkes estimates Neogen earnings at $0.28 a share for
fiscal 1997 and $0.36 for fiscal 1998.
-- Neogen shares were up 1/4 at 7-1/8.

Copyright 1997, Reuters News Service
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext